CANUEVO BIOTECH
Canuevo is developing drug delivery mechanisms for cannabinoid formulations to increase delivery efficacy. The company's drug delivery platforms are specifically designed to achieve the highest efficacy for particular chronic syndroms and conditions. They try to address the lack of standardization and acceptance of cannabis derived medication within the medical and regulatory community. Illnesses and conditions targeted by Canuevo's platforms include IBS, basal skin carcinoma, epilepsy, support medication for treating opiate dependency and pain regulation. Canuevo was started by Nils Rehmann, PhD and Daniel Carbo, MEng.
CANUEVO BIOTECH
Industry:
Biotechnology Cannabis
Founded:
2017-03-31
Address:
Fredericton, New Brunswick, Canada
Country:
Canada
Website Url:
http://www.canuevo.net
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
100 K USD
Technology used in webpage:
Domain Not Resolving
Similar Organizations
Happie Hemp
Enabling access to medicinal cannabis
Medical Cannabis Payment Solutions
MCPS's leadership team manages the world's most technologically advanced medical cannabis company
Tierra Biosciences, Inc.
Speed, scale and simplicity with protein on-demand
Current Employees Featured
Founder
